Skip to content

Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences

Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences: A 6-week Randomized Controlled Trial

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07124533
Enrollment
50
Registered
2025-08-15
Start date
2026-12-01
Completion date
2026-12-01
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, Gingival Inflammation

Keywords

Gingival Index, Plaque Index, Dentifrice, Toothpaste Tablets, Caries Experiences, Consumer Satisfaction

Brief summary

Objectives: To evaluate the effectiveness of toothpaste tablets when compared to conventional dentifrices in removing plaque. Methods: 50 participants are randomized into two groups: Denttabs toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (P). Both groups utilize their assigned dentifrice for 6 weeks. A pre and post-assessment measures the Gingival Index (GI) and Plaque Index (PI) and Decayed, Missing and Filled Teeth (DMFT). A questionnaire on the use of the product is distributed at the end of the study.

Interventions

Denttabs toothpaste tablets

Colgate Cavity Protection toothpaste

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Subjects are 18 years or older; 2. Subjects who will comply with study protocol; 3. Subjects who can read and understand the consent form; 4. Subjects available during the study period; 5. Subjects have more than 20 teeth.

Exclusion criteria

1\. Subjects under the age of 18.

Design outcomes

Primary

MeasureTime frameDescription
Plaque Index Score at BaselineChange between baseline at visit 1 and visit 2, six weeks post baselineThe quantity of plaque build-up is measured visually using the Quigley-Hein Plaque Index. The Plaque index can range from 0 to 5, with higher numbers indicating more plaque build-up.
Gingival Index Score at BaselineChange between baseline at visit 1 and visit 2, six weeks post baselineThe severity of gingival inflammation is measured visually using the Loe-Silness Gingival Index. Gingival index can range from 0 to 3, with higher numbers indicating more gingival inflammation.

Secondary

MeasureTime frameDescription
DMFT Score at BaselineChange between baseline at visit 1 and visit 2, six weeks post baselineCaries experiences is measured visually using the DMFT index. DMFT score can range from 0 to 28, with higher numbers indicating higher caries experiences.
Subject Perception of Product UseVisit 2 six weeks post study enrollmentThe perception on the product usage is measured using a survey containing questions on feel, texture, flavor, ease of use, eco-friendliness, cost and overall satisfaction. Response is on a 4 point Likert scale ranging from strongly agree (1) to strongly disagree (4).

Countries

United States

Contacts

CONTACTSo Ran Kwon, DDS, MS, PhD
sorankwon@llu.edu909 558 5118
PRINCIPAL_INVESTIGATORSo Ran Kwon, DDS, MS, PhD

Loma Linda University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026